A Noble Cause
Photo by Mark McCarty
In December, Rensselaer announced a $7 million gift from New York philanthropist Morris Marty Silverman to accelerate biotechnology research in the Capital Region. Silvermans gift will be matched by an additional $7 million from Rensselaer and will create the Noble Enterprise Constellation, a group of distinguished senior and junior faculty in biotechnology research. Research excellence and the creation of faculty constellations in key areas of information technology and biotechnology are cornerstones of the Rensselaer Plan.
Silverman, a Troy native, has been instrumental in transforming the Capital Region into a pacesetter in law, science, medicine, and higher education. In making this gift, Silvermans objective is to ensure the regions position in these areas and to take it to the next level.
The Noble Enterprise Constellation is a great opportunity to build capacity in this critical area. It is imperative that we provide the resources to bring to life our vision for research excellence, says Silverman. Through the Noble Enterprise Constellation, world-class faculty and scientific researchers will find answers to great problems in human health and will bring international recognition to the Capital Regions leadership in biotechnology. The flame we light will ignite progress into the 22nd century.
Ultimately, Silvermans objective is to provide our children a better place to live, a place to which they will want to return and where they will make their fortunes.
It is intended that Noble Enterprise Constellation faculty will hold joint appointments at the Wadsworth Center of the New York State Department of Health, and that their work in regenerative medicine and tissue engineering will add impetus to the newly formed Capital Region Biotechnology Consortium, whose membership includes Rensselaer, the Wadsworth Center, Albany Medical Center, and the University at Albany. Scientific research in these fields now focuses on the understanding of basic molecular and cellular processes leading to the replacement of full functionality of tissues, even for complex organs such as the liver, pancreas, and cardiovascular systems.